Literature DB >> 2824038

Clonal analysis of radiation leukemia virus-induced leukemic and preleukemic murine cells.

Y Ben-David1, E Yefenof, M Kotler.   

Abstract

Clonality of radiation leukemia virus (RadLV)-induced thymic lymphomas was determined by detection of rearrangements in the genetic locus coding for the beta chain of the T-cell receptor (T beta). Unique T beta rearrangements were detected in four of six lymphomas. Two of the T beta-rearranged thymic lymphomas and two in which such a rearrangement was not detected had a biallelic deletion of C beta 1. With an anti-RadLV monoclonal antibody it was found that 1-2 days after virus inoculation more than one-third of the cells in the thymus were infected by the virus. The frequency of virus-positive cells gradually declined and persisted at 1-2% until the appearance of a clonal lymphoma at which time virtually all the cells in the thymus were virus positive. Transfer of thymocytes from a single, preleukemic mouse 21 days post-virus inoculation into several adoptive recipients resulted in donor-type thymic lymphomas in the majority of the mice. T beta rearrangement analysis revealed that these lymphomas were clonal and derived from different potentially leukemic (preleukemic) cells in the thymus of the donor mouse. Eleven of 15 lymphomas had a biallelic deletion of C beta 1. These results suggest that clonal, RadLV-induced thymomas are selected from an oligoclonal, RadLV-infected preleukemic T-cell population.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2824038

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

1.  Radiation leukemia virus common integration at the Kis2 locus: simultaneous overexpression of a novel noncoding RNA and of the proximal Phf6 gene.

Authors:  Séverine Landais; Renaud Quantin; Eric Rassart
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

2.  Potentiation of T cell immunity against radiation-leukemia-virus-induced lymphoma by polysaccharide K.

Authors:  E Yefenof; E Einat; E Klein
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

3.  T cell survival and function requires the c-Abl tyrosine kinase.

Authors:  Isabelle Silberman; Ronit Vogt Sionov; Valentina Zuckerman; Sue Haupt; Zehavit Goldberg; Andreas Strasser; Zami S Ben-Sasson; Michal Baniyash; Anthony J Koleske; Ygal Haupt
Journal:  Cell Cycle       Date:  2008-12-23       Impact factor: 4.534

4.  Treatment of premalignancy: prevention of lymphoma in radiation leukemia virus-inoculated mice by cyclosporin A and immunotoxin.

Authors:  E Yefenof; G Abboud; S Epszteyn; E S Vitetta
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-15       Impact factor: 11.205

5.  Antitumor effects of ketoconazole and trifluoperazine in murine T-cell lymphomas.

Authors:  S Naftalovich; E Yefenof; Y Eilam
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

6.  Prophylactic intervention in radiation-leukemia-virus-induced murine lymphoma by the biological response modifier polysaccharide K.

Authors:  E Yefenof; I Gafanovitch; E Oron; M Bar; E Klein
Journal:  Cancer Immunol Immunother       Date:  1995-12       Impact factor: 6.968

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.